Dr. Carl Dieffenbach: 7th International AIDS Society (IAS) Conference Highlights Value of Treatment Cascade – Day 2
July 2, 2013 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Yesterday, July 1, was the first full day of the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia—the world’s largest scientific conference on HIV/AIDS. This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID, to share daily highlights from the conference via Skype.
Dr. Dieffenbach relayed that one of the themes that continues to emerge from the conference is that HIV is a chronic manageable disease and that the HIV treatment cascade (also known as the “care continuum”) serves an important metric for identifying issues and opportunities related to improving the delivery of services to people living with HIV, both on the public health policy level as well as on the front-line level in physicians’ offices. Please see his reflections, below.
For more about the HIV treatment cascade, please see our previous blog posts on this important topic.
We invite you to check back tomorrow for more reports from Dr. Dieffenbach about the exciting scientific developments being released at the IAS Conference.
To learn more about the IAS Conference, please visit the conference website or follow the conference on Facebook and Twitter .
- See more at: http://blog.aids.gov/2013/07/dr-carl-dieffenbach-7th-international-aids-society-ias-conference-highlights-value-of-treatment-cascade-day-2.html#sthash.HK3Dfcuu.dpufDr. Dieffenbach relayed that one of the themes that continues to emerge from the conference is that HIV is a chronic manageable disease and that the HIV treatment cascade (also known as the “care continuum”) serves an important metric for identifying issues and opportunities related to improving the delivery of services to people living with HIV, both on the public health policy level as well as on the front-line level in physicians’ offices. Please see his reflections, below.
For more about the HIV treatment cascade, please see our previous blog posts on this important topic.
We invite you to check back tomorrow for more reports from Dr. Dieffenbach about the exciting scientific developments being released at the IAS Conference.
To learn more about the IAS Conference, please visit the conference website or follow the conference on Facebook and Twitter .
Highlights from the 7th International AIDS Society (IAS) Conference Opening Session
July 1, 2013 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
June 30, 2013, was the opening plenary of the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. We asked Dr. Carl Dieffenbach, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID), to share highlights from the conference via Skype. Please see his reflections, below.
Dr. Dieffenbach will be sharing highlights from the IAS Conference every day, and we invite you to check back regularly to hear about the exciting new developments in research from the largest scientific conference on HIV/AIDS.
Watch conference highlights at http://www.youtube.com/iasconference . To learn more about the IAS Conference, please visit the conference website or follow the conference on Facebook and Twitter .
- See more at: http://blog.aids.gov/2013/07/highlights-from-the-7th-international-aids-society-ias-conference-opening-session.html#sthash.U122E71o.dpuf Dr. Dieffenbach will be sharing highlights from the IAS Conference every day, and we invite you to check back regularly to hear about the exciting new developments in research from the largest scientific conference on HIV/AIDS.
Watch conference highlights at http://www.youtube.com/iasconference . To learn more about the IAS Conference, please visit the conference website or follow the conference on Facebook and Twitter .
No hay comentarios:
Publicar un comentario